Funded by
the European Union

🧪 New Insights: Mortality Risks from SARS-CoV-2 Variants

The EuCARE project has published a comprehensive study examining hospital mortality across Wild-type, Alpha, Delta, and Omicron waves of SARS-CoV-2. Here’s what you need to know:

🔬 Key Findings:

  • Declining Mortality: In-hospital mortality has significantly decreased over time, especially after the emergence of Omicron.
  • The Role of Age: Older adults remain at higher risk, regardless of variant, underscoring the need for targeted interventions.
  • Impact of Immunity: Vaccination and prior infections are critical in reducing mortality risk, with no differences observed in unvaccinated patients across variants.
  • Global Perspective: The study analyzed data from 38,585 patients across 10 centers in 9 countries, offering valuable multinational insights.

📢 Policy Implications:
This study highlights the importance of targeted vaccination campaigns, robust public health surveillance, and global collaboration to ensure equitable vaccine access and better preparedness for emerging variants.

🌍 Let’s continue working together to combat the evolving challenges of COVID-19.

🔗 Read below the full Policy Brief!

Leave a Comment

Your email address will not be published. Required fields are marked *